🟢 Edesa Biotech is trading 5% up in pre-market after August 20 $25 million offering pricing

Edesa Biotech is trading 5.19% up now at $4.66 after rebounding following the August 20 pricing of its $25 million underwritten public offering.

• The offering was priced at $5.50 per common-share unit with accompanying warrants.
• Recent coverage attributes the rebound to post-offering trading activity.
• No separate August 24 announcement was identified; the move follows consecutive declines on August 20 and August 21.